John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Axsome Therapeutics
AXSM
$10.8B
| $1.29M | ﹤0.01% |
+15,900
| New | +$1.19M |
|
1802
CALL
Avis
CAR
$5.13B
| $1.29M | ﹤0.01% |
34,600
-90,900
| -72% | -$3.2M |
|
1803
PUT
JetBlue
JBLU
$1.92B
| $1.29M | ﹤0.01% |
88,500
+61,300
| +225% | +$841K |
|
1804
Cencora
COR
$62.6B
| $1.28M | ﹤0.01% |
+13,135
| New | +$1.31M |
|
1805
Century Casinos
CNTY
$35.7M
| $1.28M | ﹤0.01% |
200,140
+87,089
| +77% | +$503K |
|
1806
CALL
PetMed Express
PETS
$38.2M
| $1.28M | ﹤0.01% |
39,800
+1,500
| +4% | +$46.2K |
|
|
MIK
1807
PUT
DELISTED
Michaels Stores, Inc
MIK
| $1.27M | ﹤0.01% |
98,000
+67,500
| +221% | +$686K |
|
1808
CALL
DXC Technology
DXC
$1.74B
| $1.27M | ﹤0.01% |
49,400
-9,900
| -17% | -$211K |
|
1809
CALL
NXP Semiconductors
NXPI
$56.7B
| $1.27M | ﹤0.01% |
8,000
-100
| -1% | -$14.7K |
|
1810
International Money Express
IMXI
$425M
| $1.27M | ﹤0.01% |
81,674
+40,868
| +100% | +$633K |
|
|
BPFH
1811
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $1.27M | ﹤0.01% |
149,830
-90,524
| -38% | -$641K |
|
1812
Fabrinet
FN
$15.5B
| $1.26M | ﹤0.01% |
+16,277
| New | +$1.11M |
|
1813
CALL
Deckers Outdoor
DECK
$12.1B
| $1.26M | ﹤0.01% |
26,400
+2,400
| +10% | +$106K |
|
1814
State Street Materials Select Sector SPDR ETF
XLB
$8.88B
| $1.26M | ﹤0.01% |
+34,874
| New | +$1.19M |
|
|
SIX
1815
PUT
DELISTED
Six Flags Entertainment Corp.
SIX
| $1.26M | ﹤0.01% |
37,000
-9,500
| -20% | -$260K |
|
1816
PUT
Groupon
GRPN
$797M
| $1.26M | ﹤0.01% |
+33,200
| New | +$912K |
|
1817
CALL
LGI Homes
LGIH
$1.37B
| $1.26M | ﹤0.01% |
11,900
+4,600
| +63% | +$524K |
|
1818
PUT
Omnicom Group
OMC
$24.2B
| $1.26M | ﹤0.01% |
20,200
-40,500
| -67% | -$2.31M |
|
|
1819
PUT
PetMed Express
PETS
$38.2M
| $1.26M | ﹤0.01% |
39,300
+6,000
| +18% | +$185K |
|
1820
CALL
GDS Holdings
GDS
$6.61B
| $1.25M | ﹤0.01% |
13,400
-4,300
| -24% | -$382K |
|
|
CUTR
1821
DELISTED
Cutera, Inc.
CUTR
| $1.25M | ﹤0.01% |
51,980
+27,456
| +112% | +$587K |
|
1822
Avalo Therapeutics
AVTX
$1.06B
| $1.25M | ﹤0.01% |
165
-40
| -20% | -$278K |
|
1823
Ooma
OOMA
$566M
| $1.25M | ﹤0.01% |
86,817
-6,191
| -7% | -$91.4K |
|
1824
Airgain
AIRG
$69.7M
| $1.25M | ﹤0.01% |
70,253
+49,227
| +234% | +$685K |
|
1825
CALL
Take-Two Interactive
TTWO
$43.6B
| $1.25M | ﹤0.01% |
6,000
-21,000
| -78% | -$3.67M |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.